Termination of Bio Out-Licensing Agreement... How to Secure Investment Capacity Through Credit and Margin Repayment
The stock price of a domestic bio company declined after the clinical trial for a new drug candidate that had been out-licensed overseas was halted. As the related contract has been terminated, the candidate is expected to be returned. The company will also find it difficult to receive additional milestone payments that could have been earned depending on future development achievements. However, it is reported that the upfront payment already received will not need to be returned. The company plans to review whether to proceed with further development of the returned candidate. In addition, another candidate from the company recently received approval for a clinical trial in the United States, making it necessary to track the progress of each research project.
Credit and margin traders observing the company’s future development direction may need to reorganize their asset management schedules along with their holding plans. Checking the maturity dates and actual interest rates of prior transactions can help understand the current financial structure. Credit and margin refinancing services can be considered as an option by comparing the ongoing transaction terms, interest rates, and repayment methods. Comparing usage costs according to the expected holding period enables investors to choose the operating method that best suits their investment goals.
Meanwhile, interest in stock loans continues to rise, as more investors turn to stock loans to leverage greater funds for stock purchases and avoid missing investment opportunities.
Another advantage of stock loans is that even if margin or credit users face the risk of forced liquidation due to a sharp stock price drop, they can simply switch over without providing additional collateral or selling stocks, and then wait for a rebound.
◆ AllNewStockLoan launches a product with the lowest annual interest rate in the industry at 5%!
AllNewStockLoan has launched a securities-linked credit product that allows all investors to experience stock loans at an industry-low interest rate in the 5% range. The product can be used not only for stock purchases but also for refinancing margin/credit with securities firms, and it can be leveraged up to four times including self-capital, regardless of credit rating. In addition, investors using the alternative trading system (NXT) can also take advantage of this service.
If you would like to know more about AllNewStockLoan, you can contact the customer service center (☎1599-8666) to conveniently speak with a professional advisor at any time, regardless of your loan approval status.
○ Industry-low interest rate product in the 5% range launched!
○ ETF trading available
○ Stock funds can be leveraged up to four times! (Including personal capital)
○ Immediate same-day refinancing of securities margin/credit available!
○ Alternative trading system (NXT) supported
○ Even stocks difficult to purchase with existing securities firm credit or stock loans are now OK!
* AllNewStockLoan customer service center: 1599-8666
Go to: https://allnewstockloan.co.kr
Neosapience, SkyLabs, Orum Therapeutics, Wooree Technology, JNTC
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.